Request Deal Involvement

Catalent to acquire gene therapy company Paragon Bioservices for $1.2bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Kirkland & Ellis

legal advisors

Kirkland & Ellis

William Blair & Co

financial advisors

William Blair & Co

Gordon Feinblatt

legal advisors

Gordon Feinblatt

Leonard Green & Partners

debt providers

Leonard Green & Partners

Latham & Watkins

legal advisors to debt providers

Latham & Watkins

Fried Frank Harris Shriver & Jacobson

legal advisors

Fried Frank Harris Shriver & Jacobson

Centerview Partners

financial advisors

Centerview Partners

or

Principals

PARAGON BIOSERVICES

target

PARAGON BIOSERVICES

CATALENT INC

bidder

CATALENT INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Catalent to acquire gene therapy company Paragon Bioservices for $1.2bn.